AzTrials
AzTrials

Cognitive Impairment - e.g. DementiaNCT02199782

Pilot Study of Cognitive Assessment in Welsh Speakers

A study testing Welsh language Cognitive Assessment in people with Cognitive Impairment - e.g. Dementia, run by Conor Martin at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

19% of Wales' population speaks Welsh. Under the Welsh Language Act 1993, every public body providing services to the public in Wales has to prepare a scheme setting out how it will provide those services in Welsh. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Cognitive Impairment - e.g. Dementia
What is being tested?
Welsh language Cognitive Assessment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited Kingdom
Study dates
Feb 2015to Oct 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Welsh Speakers - self-identify as first-language Welsh
  • Diagnosis of Dementia - recorded in patient's case notes

Who cannot join

  • Refusal
  • Intercurrent illness
  • Blind/any other disability which may prevent participant from fully completing Cognitive Assessment

Trial locations and contacts

1 site in 1 country.

Conor Martin, MBBCh contact

+447525931775

conor.martin@live.co.uk

United Kingdom1 site
  • Ysbyty Glan Clwyd

    Bodelwyddan, Denbighshire, LL18 5UJ

    Conor Martin, MBBCh, +447525931775, conor.martin@live.co.uk

    Conor Martin, MBBCh

Other trials in United Kingdom

About this study

19% of Wales' population speaks Welsh. Under the Welsh Language Act 1993, every public body providing services to the public in Wales has to prepare a scheme setting out how it will provide those services in Welsh.

Diagnosing dementia requires a comprehensive assessment, an essential component of which is a cognitive assessment tool, which takes the form of a questionnaire. In clinical practice, this is currently only available through the medium of English.

Read more

The investigators objective is to measure the difference between Cognitive Assessment scores (using the Montreal cognitive assessment (MoCA)), when done in English and Welsh, in those who are cognitively impaired and whose first language is Welsh. The investigators predict that there will be a significant difference in scores in favour of the Welsh-medium tests, thus proving that the current mode of administering the test is prejudiced against patients whose first language is Welsh.

If the investigators predictions are correct, then the investigators would seek to introduce a validated Welsh-language cognitive assessment tool to the domain of the Welsh NHS.

Being tested
Welsh language Cognitive Assessment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Welsh language Cognitive AssessmentOther

    This intervention may intervene by displaying a more realisitic reflection of the patient's cognitive ability by assessing the patient in their first language

Study groups in NCT02199782
Study groupRoleWhat they receive
WelshActive comparatorParticipants will complete the cognitive assessment in Welsh and in English these will be compared to assess whether first language Welsh speakers perform better in Welsh.
Receives: Other: Welsh language Cognitive Assessment
EnglishActive comparatorParticipants will complete the cognitive assessment in Welsh and in English these will be compared to assess whether first language Welsh speakers perform better in Welsh.
Receives: Other: Welsh language Cognitive Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in Cognitive Assessment Score between Welsh and English

    Measured: at 0 and 48 hrs

Secondary outcomes (1)
  1. To measure the differences between participants' scores in Welsh and English and compare between different types of Dementia

    We will records each participant's type of cognitive decline - e.g. Alzheimer's, Vascular, Frontal, Lewy Body, etc, and compare the differences in scores - to see whether different types of dementia will perform significantly worse or better in their first and second languages (Welsh and English).

    Measured: 0 and 48hrs

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2014 (estimated)
  2. Study startFeb 2015
  3. Primary completionAug 2015 (estimated)
  4. Study completionOct 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02199782
Sponsor's protocol ID
BCUHB - PS - CAWS - 1
Status last verified
Jul 2014
First submitted
15 Jul 2014
Last updated
24 Jul 2014
Results posted
No
Data monitoring committee
No

Publications

  • Cummings JL, Benson F, Hill MA, Read S. Aphasia in dementia of the Alzheimer type. Neurology. 1985 Mar;35(3):394-7. doi: 10.1212/wnl.35.3.394.

    PubMed 3974897
  • Mendez MF, Perryman KM, Ponton MO, Cummings JL. Bilingualism and dementia. J Neuropsychiatry Clin Neurosci. 1999 Summer;11(3):411-2. doi: 10.1176/jnp.11.3.411. No abstract available.

    PubMed 10440021

Questions about this trial

What is this clinical trial studying?

A study testing Welsh language Cognitive Assessment in people with Cognitive Impairment - e.g. Dementia, run by Conor Martin at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Jul 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Conor Martin, MBBCh (+447525931775, conor.martin@live.co.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in Cognitive Assessment Score between Welsh and English (time frame: at 0 and 48 hrs). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02199782, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in